{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:02:53Z","timestamp":1778475773006,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,17]]},"DOI":"10.7759\/cureus.64739","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T15:30:25Z","timestamp":1721230225000},"source":"Crossref","is-referenced-by-count":6,"title":["Exploring the Cytotoxic and Anticancer Potential of Naringin on Oral Cancer Cell Line"],"prefix":"10.7759","author":[{"given":"Beniel","family":"Vincer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jospin","family":"Sindya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeevitha","family":"Rajanathadurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elumalai","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Cancer - an overview","volume":"40","author":"Krieghoff-Henning E","year":"2017","unstructured":"Krieghoff-Henning E, Folkerts J, Penzkofer A, Weg-Remers S. Cancer - an overview. Med Monatsschr Pharm. 2017, 40:48-54.","journal-title":"Med Monatsschr Pharm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.200658","article-title":"Cancer and cure: a critical analysis","volume":"53","author":"Roy PS","year":"2016","unstructured":"Roy PS, Saikia BJ. Cancer and cure: a critical analysis. Indian J Cancer. 2016, 53:441-2. 10.4103\/0019-509X.200658","journal-title":"Indian J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605778","article-title":"Derivation and validation of a risk-factor model for detection of oral potentially malignant disorders in populations with high prevalence","volume":"103","author":"Amarasinghe HK","year":"2010","unstructured":"Amarasinghe HK, Johnson NW, Lalloo R, Kumaraarachchi M, Warnakulasuriya S. Derivation and validation of a risk-factor model for detection of oral potentially malignant disorders in populations with high prevalence. Br J Cancer. 2010, 103:303-9. 10.1038\/sj.bjc.6605778","journal-title":"Br J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.sintl.2020.100046","article-title":"Oral cancer diagnosis and perspectives in India","volume":"1","author":"Borse V","year":"2020","unstructured":"Borse V, Konwar AN, Buragohain P. Oral cancer diagnosis and perspectives in India. Sens Int. 2020, 1:100046. 10.1016\/j.sintl.2020.100046","journal-title":"Sens Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19020875","article-title":"Burden of oral cancer on the 10 most populous countries from 1990 to 2019: estimates from the Global Burden of Disease Study 2019","volume":"19","author":"Zhang SZ","year":"2022","unstructured":"Zhang SZ, Xie L, Shang ZJ. Burden of oral cancer on the 10 most populous countries from 1990 to 2019: estimates from the Global Burden of Disease Study 2019. Int J Environ Res Public Health. 2022, 19:875. 10.3390\/ijerph19020875","journal-title":"Int J Environ Res Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1875-595x.2012.00131.x","article-title":"Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives","volume":"63","author":"Gupta B","year":"2013","unstructured":"Gupta B, Ariyawardana A, Johnson NW. Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. Int Dent J. 2013, 63:12-25. 10.1111\/j.1875-595x.2012.00131.x","journal-title":"Int Dent J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-010-0157-3","article-title":"Oral premalignant lesions: from a clinical perspective","volume":"16","author":"Amagasa T","year":"2011","unstructured":"Amagasa T, Yamashiro M, Uzawa N. Oral premalignant lesions: from a clinical perspective. Int J Clin Oncol. 2011, 16:5-14. 10.1007\/s10147-010-0157-3","journal-title":"Int J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1596\/978-1-4648-0349-9_ch5","article-title":"Oral cancer: prevention, early detection, and treatment","author":"Sankaranarayanan R","year":"2015","unstructured":"Sankaranarayanan R, Ramadas K, Amarasinghe H, Subramanian S, Johnson N. Oral cancer: prevention, early detection, and treatment. Cancer: disease control priorities, third edition (volume 3). Gelband H, Jha P, Sankaranarayanan R, Horton S (ed): The International Bank for Reconstruction and Development\/The World Bank, Washington, DC; 2015. 3:85-99. 10.1596\/978-1-4648-0349-9_ch5"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11070302","article-title":"Controlled drug delivery systems for oral cancer treatment-current status and future perspectives","volume":"11","author":"Ketabat F","year":"2019","unstructured":"Ketabat F, Pundir M, Mohabatpour F, et al.. Controlled drug delivery systems for oral cancer treatment-current status and future perspectives. Pharmaceutics. 2019, 11:302. 10.3390\/pharmaceutics11070302","journal-title":"Pharmaceutics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/nu15081896","article-title":"Phytochemicals in cancer treatment and cancer prevention-review on epidemiological data and clinical trials","volume":"15","author":"Rudzi\u0144ska A","year":"2023","unstructured":"Rudzi\u0144ska A, Juchaniuk P, Oberda J, Wi\u015bniewska J, Wojdan W, Szklener K, Ma\u0144dziuk S. Phytochemicals in cancer treatment and cancer prevention-review on epidemiological data and clinical trials. Nutrients. 2023, 15:1896. 10.3390\/nu15081896","journal-title":"Nutrients"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1217001","article-title":"Research progress on the anti-tumor effect of naringin","volume":"14","author":"He J","year":"2023","unstructured":"He J, Zhang HP. Research progress on the anti-tumor effect of naringin. Front Pharmacol. 2023, 14:1217001. 10.3389\/fphar.2023.1217001","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/toxins2040517","article-title":"Phytochemicals in cancer prevention and therapy: truth or dare?","volume":"2","author":"Russo M","year":"2010","unstructured":"Russo M, Spagnuolo C, Tedesco I, Russo GL. Phytochemicals in cancer prevention and therapy: truth or dare?. Toxins (Basel). 2010, 2:517-51. 10.3390\/toxins2040517","journal-title":"Toxins (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071686","article-title":"Naringin and naringenin: their mechanisms of action and the potential anticancer activities","volume":"10","author":"Stabrauskiene J","year":"2022","unstructured":"Stabrauskiene J, Kopustinskiene DM, Lazauskas R, Bernatoniene J. Naringin and naringenin: their mechanisms of action and the potential anticancer activities. Biomedicines. 2022, 10:1686. 10.3390\/biomedicines10071686","journal-title":"Biomedicines"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28155623","article-title":"Phytochemical properties, extraction, and pharmacological benefits of naringin: a review","volume":"28","author":"Shilpa VS","year":"2023","unstructured":"Shilpa VS, Shams R, Dash KK, et al.. Phytochemical properties, extraction, and pharmacological benefits of naringin: a review. Molecules. 2023, 28:5623. 10.3390\/molecules28155623","journal-title":"Molecules"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105264","article-title":"Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: efficacy and molecular mechanisms of action, a comprehensive narrative review","volume":"171","author":"Memariani Z","year":"2021","unstructured":"Memariani Z, Abbas SQ, Ul Hassan SS, Ahmadi A, Chabra A. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: efficacy and molecular mechanisms of action, a comprehensive narrative review. Pharmacol Res. 2021, 171:105264. 10.1016\/j.phrs.2020.105264","journal-title":"Pharmacol Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.22038\/IJBMS.2024.73824.16048","article-title":"Protective effects of naringin against oxaliplatin-induced testicular damage in rats: involvement of oxidative stress, inflammation, endoplasmic reticulum stress, apoptosis, and histopathology","volume":"27","author":"Akaras N","year":"2024","unstructured":"Akaras N, G\u00fcr C, Caglayan C, Kandemir FM. Protective effects of naringin against oxaliplatin-induced testicular damage in rats: involvement of oxidative stress, inflammation, endoplasmic reticulum stress, apoptosis, and histopathology. Iran J Basic Med Sci. 2024, 27:466-74. 10.22038\/IJBMS.2024.73824.16048","journal-title":"Iran J Basic Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-023-04222-2","article-title":"Anti-microbial and anti-cancer efficacy of acetone extract of Rosa chinensis against resistant strain and lung cancer cell line","volume":"23","author":"Kuppusamy KM","year":"2023","unstructured":"Kuppusamy KM, Selvaraj S, Singaravelu P, et al.. Anti-microbial and anti-cancer efficacy of acetone extract of Rosa chinensis against resistant strain and lung cancer cell line. BMC Complement Med Ther. 2023, 23:406. 10.1186\/s12906-023-04222-2","journal-title":"BMC Complement Med Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01565-1","article-title":"CRISPR\/Cas9 and next generation sequencing in the personalized treatment of cancer","volume":"21","author":"Selvakumar SC","year":"2022","unstructured":"Selvakumar SC, Preethi KA, Ross K, et al.. CRISPR\/Cas9 and next generation sequencing in the personalized treatment of cancer. Mol Cancer. 2022, 21:83. 10.1186\/s12943-022-01565-1","journal-title":"Mol Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2023.05.115","article-title":"Investigating the synergistic potential of TRAIL and SAHA in inducing apoptosis in MOLT-4 cancer cells","volume":"676","author":"Mohammad Mirzapour M","year":"2023","unstructured":"Mohammad Mirzapour M, Farshdousti Hagh M, Marofi F, Solali S, Alaei A. Investigating the synergistic potential of TRAIL and SAHA in inducing apoptosis in MOLT-4 cancer cells. Biochem Biophys Res Commun. 2023, 676:13-20. 10.1016\/j.bbrc.2023.05.115","journal-title":"Biochem Biophys Res Commun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2012.10.008","article-title":"Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway","volume":"215","author":"Elumalai P","year":"2012","unstructured":"Elumalai P, Gunadharini DN, Senthilkumar K, et al.. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway. Toxicol Lett. 2012, 215:131-42. 10.1016\/j.toxlet.2012.10.008","journal-title":"Toxicol Lett"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20193686","article-title":"Naringin alleviates methotrexate-induced liver injury in male albino rats and enhances its antitumor efficacy in HepG2 cells","volume":"40","author":"Elsawy H","year":"2020","unstructured":"Elsawy H, Algefare AI, Alfwuaires M, Khalil M, Elmenshawy OM, Sedky A, Abdel-Moneim AM. Naringin alleviates methotrexate-induced liver injury in male albino rats and enhances its antitumor efficacy in HepG2 cells. Biosci Rep. 2020, 40:BSR20193686. 10.1042\/BSR20193686","journal-title":"Biosci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/272393-exploring-the-cytotoxic-and-anticancer-potential-of-naringin-on-oral-cancer-cell-line","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T15:30:30Z","timestamp":1721230230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/272393-exploring-the-cytotoxic-and-anticancer-potential-of-naringin-on-oral-cancer-cell-line"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.64739","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,17]]}}}